IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.
about
microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2.IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View.
P2860
IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
IRS2 silencing increases apopt ...... myeloproliferative neoplasms.
@en
type
label
IRS2 silencing increases apopt ...... myeloproliferative neoplasms.
@en
prefLabel
IRS2 silencing increases apopt ...... myeloproliferative neoplasms.
@en
P2093
P2860
P50
P356
P1433
P1476
IRS2 silencing increases apopt ...... e myeloproliferative neoplasms
@en
P2093
Adriana da Silva Souza Duarte
Christopher A Eide
Cristina E Tognon
Fernando F Costa
Patricia Favaro
Paula de Melo Campos
Renata Scopim-Ribeiro
Samantha L Savage
Sara T Olalla Saad
P2860
P304
P356
10.18632/ONCOTARGET.6851
P407
P577
2016-02-01T00:00:00Z